user avatar
GlomCon
@GlomCon
GlomCon is a resource for the kidney community to exchange ideas, learn, educate, and collaborate on projects. Membership via my.glomcon.org
Joined May 2016
Posts
  • Pinned
    user avatar
    🚨 NOW OPEN: Pre-Application for Rare Kidney Disease/Glomerular Disease Centers of Excellence! 🚨 Join exceptional institutions, clinics, and healthcare organizations to become designated Centers of Excellence. 🎯 What you'll gain: ✅ Access to premier fellowship programs ✅
  • user avatar
    #KidneyWk had tons of exciting advances in glomerular diseases. Because it is more than one can absorb in a limited time, we have gone through all GN-related talks, presentations, and abstracts and will share some highlights here over the next few weeks here 🧵👇
  • user avatar
    Check out this Infographic about lupus nephritis by Dr. Ana Naidas @AnaNaidas a GlomCon Virtual Glomerular Disease Fellow and Nephrologist at Philippine General Hospital, Philippines
  • user avatar
    A comprehensive summary in 5 min 👇 PROTECT Study in IgAN by Dr. Jonathan Barratt @IgAN_JBarratt ➡️Study design ➡️Patient characteristics ➡️Intervention ➡️Outcomes ➡️Interpretation reachmd.com/programs/cme/p…
  • user avatar
    ⚡️Are you a nephrology fellow or early career nephrologist? GlomCon is now accepting applications for the first class of its virtual glomerular disease fellowship. Work with an elite group of expert faculty. Learn, teach and network! Apply now at edu.glomcon.org
  • user avatar
    A frequent question: Can you sparsentan and SGLT2i be combined, and do they provide additive benefits? The PROTECT Open-Label Extension (OLE) Substudy and SPARTACUS is aiming to answer this question 👇 asn-online.org/education/kidn…
  • user avatar
    We are delighted to announce the first class for our virtual Glomerular Diseases Fellowship Program. Join us in welcoming 52 amazing fellows from 19 countries! #GlomFellows #FutureExperts #NephTwitter @SaynaNorouzi @BetterCallSeeth @nephrologista @poyanmehr
    00:00
  • user avatar
    A comprehensive summary in 5 min 🚨 PROTECT Study in IgAN by Dr. Jonathan Barratt @IgAN_JBarratt Study design 👉Patient characteristics 👉Intervention 👉Outcomes 👉Interpretation reachmd.com/programs/cme/p…
  • user avatar
    Anticoagulant-related nephropathy by Dr. Irene Martin, Dr. Paolo Nikolai So, Dr. Tiffany Caza and Dr. Mohamed Hassanein Read here 👉 pubs.glomcon.org/anticoagulant-… #GlomCon
  • user avatar
    Lupus Nephritis Treatment – What is Next? A review of new treatments, therapeutic targets, and clinical trials by Dr. Sayali B. Thakare @SayaliBThakare in GlomCon Pubs pubs.glomcon.org/lupus-nephriti…
  • user avatar
    ⚡️Are you a nephrology fellow or an early career nephrologist? GlomCon accepts applications for the third class of its virtual glomerular disease fellowship. Work with an elite group of expert faculty. Learn, teach and network! Apply now at edu.glomcon.org
  • user avatar
    We are excited to announce the launch of GlomPedia 📖 The essential guide to glomerular diseases at your fingertips! GlomPedia is your go-to eBook library for diagnosing and managing glomerular diseases. 👉 Download it for free today on the Apple App Store and Google Play.
  • user avatar
    Approach to Pregnancy in Lupus Nephritis 🤰🏽🦋 Benjamin Tan
Paolo Nikolai So
Anoushka Krishnan
Sol Carriazo
Josélyn Reyes Bahamonde
Tanuj Moses Lamech
Mohamed Hassanein
Edgar Lerma
 And Nasim Wiegley
On behalf of theGlomCon Editorial Team kidneymedicinejournal.org/article/S2590-…
  • user avatar
    GlomCon leadership team meeting for lunch to discuss their vision and passion for glomerular disease care Bunch of young, fierce, and ambitious people 💪 #kidneystrong #kidneywk